YN001

· Beijing Inno Medicine Co., Ltd.

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for YN001, covering 2024-11-18 to 2026-04-09. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis [Phase 2]